Fundraising FoxTreo Ventures, Llc — Full Portfolio
15 tracked investments · listed companies and verified rows first
CVRx develops Barostim, an implantable medical device that uses baroreceptor activation to treat heart failure patients and improve their functional capacity and quality of life.
BiotechHealthtechMedical DevicesAustin, US
Craig Palmer(Executive Officer)inNadim Yared(Executive Officer, Director)inDean Bruhn-Ding(Executive Officer)inJohn Brintnall(Executive Officer)inLiz Galle(Executive Officer)Kevin Hykes(President, Chief Executive Officer & Director)in
Co-investorsABS VenturesNew Enterprise Associates (NEA)Windham Capital PartnersYsios CapitalAction Potential Venture Capital Ltd.Hatteras Venture Partners+1 more
Avivomed is a medical device company developing minimally invasive neuromodulation therapies for patients with obstructive sleep apnea.
BiotechDeep TechHealthtechMedical DevicesRoseville, US
Lynn Elliott(Co-Founder)Mudit Jain(Co-Founder)Paul Mazanec(Chief Executive Officer)inStephen Masson(Executive Officer, Director)
BoardTheresa C. Pappas(Director)Ketan Patel(Director)in
Co-investorsHatteras Venture PartnersF-Prime Capital
iRiva Medical is a development-stage medical device company building neuromodulation technology platforms to treat patients with chronic diseases.
BiotechHealthtechMedical DevicesMinneapolis, US
Mudit K. Jain(Co-Founder and Chairman of the Board)Lynn Elliott(Co-Founder and Director)inSteve Masson(President & CEO)in
Co-investorsHatteras Venture PartnersF-Prime Capital
NuXcel is a global medical device accelerator that founds and incubates bioelectronics and neuromodulation startups addressing large unmet clinical needs, using a lean innovation model.
Deep TechHealthtechMedical Devices
Co-investorsAmzak HealthAPERTURE Venture PartnersNorwest Venture PartnersOSF VenturesU.S. Venture Partners
HYALEX Orthopaedics develops a synthetic cartilage platform for joint repair in orthopaedic surgery.
HealthtechMedical DevicesLexington, US
Carl Vause(Chief Executive Officer and President)inMira Sahney(Executive Officer, Director)inDavid Myung(Director)
BoardMichael Hawkins(Director)Wende Hutton(Director)inWilliam Harrington(Director)in
Board seatBrad H. Vale· per SEC Form D
Co-investorsCanaan PartnersOUP (Osage University Partners)Johnson & Johnson Innovation – JJDC
Noctrix Health develops clinically validated wearable therapeutics for managing chronic neurological disorders, with its first product Nidra receiving FDA De Novo authorization and dedicated CMS HCPCS codes.
Digital HealthMedical DevicesWellness & FitnessPleasanton, US
Shri Raghunathan(Founder)inShriram Raghunathan(Executive Officer, Director)
BoardChau Khuong(Director)inAllan May(Director)Mudit Jain(Director)in
Board seatMudit K. JainTracy Pappas· per SEC Form D
Co-investorsAngelini VenturesBlue Venture FundsJoyance PartnersOrbiMedZühlke VenturesBridge Bank+2 more
ShiraTronics is a medical device company developing an implantable device to treat chronic migraine disease.
BiotechHardwareHealthtechMedical DevicesBrooklyn Park, US
Robert Binney(Executive Officer, Director)
BoardJoyce Erony(Director)inZack Scott(Director)inBrad Vale(Director)inCasey Tansey(Director)Mudit Jain(Executive Officer, Director)in
Board seatBrad H. ValeMudit K. Jain· per SEC Form D
Co-investorsAmzak HealthAPERTURE Venture PartnersBreakout VenturesGlobal BioAccess FundNorwest Venture PartnersOSF Ventures+3 more
InterVene, Inc. is a medical device company that has developed a fully integrated mechanical thrombectomy system to treat venous in-stent restenosis and residual thrombotic venous obstructions and occlusions.
BiotechHealthtechMedical DevicesMountain View, US
Fletcher Wilson(Executive Officer, Director)in
BoardThomas Fogarty(Director)Mel Schatz(Director)
Co-investorsLaunchCapitalRiverVest Venture PartnersEmergent Medical Partners, LLP
IT Asset Management Group provides IT asset disposition (ITAD), secure data destruction, and electronics recycling services for retired IT equipment.
Circular EconomyEnterprise Software
Co-investorsEmergent Medical Partners, LLP
IVEAcare develops neuromodulation and bioelectronics therapies, implantable medical devices aimed at treating chronic conditions for large patient populations.
Deep TechHealthtechMedical DevicesRoseville, US
Todd Kerkow(Co-Founder, President and CEO)inMudit Jain(Co-Founder and Chairman of the Board)Lynn(Co-Founder and Board Member)inCorey Dishmon(Director)Robert Greenberg(Director)
BoardKirk Nielsen(Director)in
Co-investorsHatteras Venture PartnersVensana Capital
NeoChord develops a medical device system for beating heart mitral valve repair in patients with mitral valve regurgitation.
Advanced ManufacturingHealthtechMedical DevicesMaple Grove, US
Todd Berg(Executive Officer, Director)inDavid H. Chung(Executive Officer, Director)inRon Nelson(Executive Officer)in
BoardCasey Tansey(Director)Mudit K. Jain(Director)Andrew ElBardissi(Director)in
Co-investorsBaird CapitalUS Venture PartnersDeerfield Management CompanyU.S. Venture Partners
Neuspera Medical develops an integrated sacral neuromodulation (iSNM) system that implants a smart neurostimulator near the sacral nerve to treat urinary urge incontinence, a symptom of overactive bladder.
BiotechHealthtechMedical DevicesSan Jose, US
Alexander Yeh(Founder)inMilton M. Morris(Executive Officer, Director)inDave Van Meter(Chief Executive Officer)Steve Paul(Chief Commercial Officer)in
Co-investorsAlumni VenturesCerity Partners VenturesForeground CapitalPortfoliaWindham Capital PartnersAction Potential Venture Capital Ltd.+2 more
SecondWave Systems develops a noninvasive, wearable ultrasound stimulation device that modulates nerves, cells, and organs deep in the body for at-home treatment of conditions such as inflammation and pain.
Digital HealthHardwareMedical Devices
Anuj Bhardwaj(Chief Executive Officer)inHubert H. Lim(Chief Scientific Officer)inJeff Heyman(Chief Operating Officer)in
Co-investorsKickstart InnovationScientific Health Development
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
HyalexPresspogo
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.